| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00384-014-2085-6 |
| P698 | PubMed publication ID | 25503801 |
| P2093 | author name string | Johannes H W de Wilt | |
| Koert P de Jong | |||
| Joost M Klaase | |||
| Marloes A G Elferink | |||
| Esther J Siemerink | |||
| P2860 | cites work | Follow-up strategies for patients treated for non-metastatic colorectal cancer | Q24243018 |
| Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer | Q28308193 | ||
| Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series | Q33777340 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial | Q34614245 | ||
| Metastatic pattern in colorectal cancer is strongly influenced by histological subtype | Q35611934 | ||
| Liver resection combined with local ablation: where are the limits? | Q37871748 | ||
| Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis | Q40073020 | ||
| Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases | Q43413801 | ||
| Loco-regional recurrence from colon cancer: a population-based study | Q44414972 | ||
| R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? | Q45674652 | ||
| Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important | Q46600473 | ||
| Computer-based decision making in medicine: A model for surgery of colorectal liver metastases. | Q51899163 | ||
| Effect of specialist decision-making on treatment strategies for colorectal liver metastases. | Q53103788 | ||
| Completeness of Cancer Registration in Limburg, the Netherlands | Q61988458 | ||
| Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study | Q79450474 | ||
| Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population | Q79804963 | ||
| Epidemiology and management of liver metastases from colorectal cancer | Q79955500 | ||
| Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease | Q84331533 | ||
| Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study | Q84791504 | ||
| Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer | Q86631655 | ||
| P433 | issue | 2 | |
| P921 | main subject | Netherlands | Q55 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 205-212 | |
| P577 | publication date | 2014-12-12 | |
| P1433 | published in | International Journal of Colorectal Disease | Q15758189 |
| P1476 | title | Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. | |
| P478 | volume | 30 |
| Q92618053 | Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study |
| Q40888514 | Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer |
| Q34477640 | Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial |
| Q47795778 | Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. |
| Q64247100 | Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer |
| Q49676399 | Analysis of the association of the expression of KiSS-1 in colorectal cancer tissues with the pathology and prognosis |
| Q39853276 | Association Between the Most Frequent Complications After Surgery for Stage I-III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences |
| Q38733789 | Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease |
| Q92486916 | Cardiovascular complications of metastatic colorectal cancer treatment |
| Q55260487 | Confirmation of a metastasis-specific microRNA signature in primary colon cancer. |
| Q64116538 | Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study |
| Q90135126 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis |
| Q94957215 | Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis |
| Q58719193 | Exome scale map of genetic alterations promoting metastasis in colorectal cancer |
| Q49291015 | HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma |
| Q42366278 | High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients. |
| Q92329260 | Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy |
| Q38638844 | How and when adjuvant treatment should be intensified in stage III colorectal cancers? |
| Q89406476 | Indeterminate Pulmonary Nodules in Resected Liver Metastases from Colorectal Cancer: A Comparison of Patient Outcomes |
| Q89503394 | Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer |
| Q49744283 | Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial |
| Q59330604 | Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition |
| Q50267350 | Nonphysician Clinicians in the Follow-Up of Resected Patients with Colorectal Cancer |
| Q38671275 | Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer |
| Q38970211 | Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway |
| Q64112597 | Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure |
| Q52889145 | Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. |
| Q55376619 | Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis. |
| Q47679286 | Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial |
| Q51382187 | Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer. |
| Q53093164 | Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC). |
| Q37367343 | Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial. |
| Q38780368 | Surveillance after curative treatment for colorectal cancer |
| Q93336605 | Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer |
| Q94322408 | Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer |
| Q90319513 | Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer |
| Q92421935 | The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival |
| Q33684362 | The association of p53 expression levels with clinicopathological features and prognosis of patients with colon cancer following surgery |
| Q47406196 | Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer |
| Q90452795 | Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality |
Search more.